1 |
Clark, M. and Cramer, R. : Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases. Tetrahedron Computer Methodology 3, 47 (1990).
DOI
|
2 |
Marshall, G., Barry, C., Bosshard, H., Dammkoehler, R. and Dunn, D. : The conformational parameter in drug design: the active analog approach. In Computer-assisted Drug Design 112, 205 (1979).
|
3 |
Soung, M., Lee, Y. and Sung, N. : 3D-QSARs of Herbicidal 2- N-Phenylisoindolin-1-one Analogues as a New Class of Potent Inhibitors of Protox. Bull. Korean Chem. Soc. 30, 613 (2009).
DOI
|
4 |
Wold, S., ohansson, E. and Cocchi, M. : PLS, partial least squares projections to latent structures. 3D QSAR in Drug Design, 523 (1993).
|
5 |
Lindberg, W., Persson, J. and Wold, S. : Partial least-squares method for spectrofluorimetric analysis of mixtures of humic acid and lignin sulfonate. Anal. Chem. 55, 643 (1983).
DOI
|
6 |
Vainio, O. : Alpha-2 adrenergic agonists and antagonists. 6th Proc Int Cong Vet Anaes, 75 (1997).
|
7 |
Andres, J. I., Alcazar, J., Alonso, J. M., Alvarez, R. M., Cid, J. M., De Lucas, A. I., Fernandez, J., Martinez, S., Nieto, C., Pastor, J., Bakker, M. H., Biesmans, I., Heylen, L. I. and Megens, A. A. : Synthesis of 3a,4-dihydro-3H- [1]benzopyrano [4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha(2)-adrenoceptor antagonistic activities: a novel series of potential antidepressants. Bioorg. Med. Chem. Lett. 13, 2719 (2003).
DOI
ScienceOn
|
8 |
Andres, J. I., Alcazar, J., Alonso, J. M., Alvarez, R. M., Bakker, M. H., Biesmans, I., Cid, J. M., De Lucas, A. I., Fernandez, J., Font, L. M., Hens, K. A., Iturrino, L., Lenaerts, I., Martinez, S., Megens, A. A., Pastor, J., Vermote, P. C. and Steckler, T. : Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity. J. Med. Chem. 48, 2054 (2005).
DOI
ScienceOn
|
9 |
Pastor, J., Alcazar, J., Alvarez, R. M., Andres, J. I., Cid, J. M., De Lucas, A. I., Diaz, A., Fernandez, J., Font, L. M., Iturrino, L., Lafuente, C., Martinez, S., Bakker, M. H., Biesmans, I., Heylen, L. I. and Megens, A. A. : Synthesis of 3a,4-dihydro- 3H-[1]benzopyrano [4,3-c]isoxazoles, displaying combined 5- HT uptake inhibiting and alpha2-adrenoceptor antago- nistic activities. Part 2: Further exploration on the cinnamyl moiety. Bioorg. Med. Chem. Lett. 14, 2917 (2004).
DOI
ScienceOn
|
10 |
Andres, J. I., Alcazar, J., Alonso, J. M., De Lucas, A. I., Iturrino, L., Biesmans, I. and Megens, A. A. : Synthesis of 7-amino-3a, 4-dihydro-3H-[1]- benzopyrano[4,3-c]isoxazole derivatives displaying combined alpha2- adrenoceptor antagonistic and 5-HT reuptake inhibiting activities. Bioorg. Med. Chem. 14, 4361 (2006).
DOI
ScienceOn
|
11 |
Tripos, S. : Molecular modeling and QSAR software on CDRom (Ver. 7.3), Tripos Associates, Inc., 1699 S. Hanley Road, Suite 303, 63144 (2001).
|
12 |
Vasan, A. and Raju, K. : Comparative analysis of Simulated Annealing, Simulated Quenching and Genetic Algorithms for optimal reservoir operation. Applied Soft Computing 9, 274 (2009).
DOI
ScienceOn
|
13 |
Tellez, S., Colpaert, F. and Marien, M. : Acetylcholine release in the rat prefrontal cortex in vivo: modulation by alpha 2- adrenoceptor agonists and antagonists. J. Neurochem. 68, 778 (1997).
|
14 |
Raiteri, M., Maura, G., Folghera, S., Cavazzani, P., Andrioli, G. C., Schlicker, E., Schalnus, R. and Gothert, M. : Modulation of 5-hydroxytryptamine release by presynaptic inhibitory alpha 2-adrenoceptors in the human cerebral cortex. Naunyn Schmiedebergs Arch. Pharmacol. 342, 508 (1990).
|
15 |
Beyer, C. E., Lin, Q., Rosenzweig-Lipson, S. and Schechter, L. E. : Alpha 2A-adrenoceptors enhance the serotonergic effects of fluoxetine. Eur. J. Pharmacol. 539, 164 (2006).
DOI
ScienceOn
|
16 |
Blier, P. : Pharmacology of rapid-onset antidepressant treatment strategies. J. Clin. Psychiatry 62 Suppl 15, 12 (2001).
DOI
|
17 |
Greene, S. A. : Pros and cons of using alpha-2 agonists in small animal anesthesia practice. Clin. Tech. Small. Anim. Pract. 14, 10 (1999).
DOI
ScienceOn
|
18 |
Sinclair, M. D. : A review of the physiological effects of alpha2- agonists related to the clinical use of medetomidine in small animal practice. Can. Vet. J. 44, 885 (2003).
|
19 |
Hirst, G. and McKirdy, H. : Presynaptic inhibition at mammalian peripheral synapse? Nature 250, 430 (1974).
DOI
|
20 |
Doze, V. A., Chen, B. X. and Maze, M. : Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 71, 75 (1989).
DOI
ScienceOn
|
21 |
Flacke, W., Flacke, J., McIntee, D., Blow, K. and Bloor, B. : Dexmedetomidine: effects of the alpha2 agonist on the isolated mammalian heart. Anesthesiology 71, A543 (1989).
DOI
|
22 |
Maze, M. : Clinical Uses of [alpha] 2 Agonists. ASA Refresher Courses in Anesthesiology 20, 133 (1992).
DOI
|
23 |
Puolivali, J., Bjorklund, M., Holmberg, M., Ihalainen, J. A., Scheinin, M. and Tanila, H. : Alpha 2C-adrenoceptor mediated regulation of cortical EEG arousal. Neuropharmacology 43, 1305 (2002).
DOI
ScienceOn
|
24 |
MacDonald, E. and Scheinin, M. : Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J. Physiol. Pharmacol. 46, 241 (1995).
|
25 |
Starke, K. : Presynaptic alpha-autoreceptors. Rev. Physiol. Biochem. Pharmacol. 107, 73 (1987).
|
26 |
Rosin, D. L., Talley, E. M., Lee, A., Stornetta, R. L., Gaylinn, B. D., Guyenet, P. G. and Lynch, K. R. : Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 372, 135 (1996).
DOI
ScienceOn
|
27 |
Orito, K., Kishi, M., Imaizumi, T., Nakazawa, T., Hashimoto, A., Mori, T. and Kambe, T. : alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator. Br. J. Pharmacol. 134, 763 (2001).
DOI
ScienceOn
|
28 |
Starke, K. : Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1 (1977).
|
29 |
Hertel, P., Fagerquist, M. V. and Svensson, T. H. : Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade. Science 286, 105 (1999).
DOI
|
30 |
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J. and Monteggia, L. M. : Neurobiology of depression. Neuron. 34, 13 (2002).
DOI
ScienceOn
|
31 |
Hindmarch, I. : Expanding the horizons of depression: beyond the monoamine hypothesis. Hum. Psychopharmacol. 16, 203 (2001).
DOI
ScienceOn
|
32 |
Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., Jr. and Trendelenburg, U. : International Union of Pharmacology nomenclature of adreno-ceptors. Pharmacol. Rev. 46, 121 (1994).
|
33 |
French, N. : Alpha 2-adrenoceptors and I2 sites in the mammalian central nervous system. Pharmacol. Ther. 68, 175 (1995).
DOI
ScienceOn
|
34 |
Bylund, D. B. : Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends. Pharmacol. Sci. 9, 356 (1988).
DOI
ScienceOn
|
35 |
Bylund, D. B. : Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J. 6, 832 (1992).
DOI
|
36 |
Bylund, D. B., Ray-Prenger, C. and Murphy, T. J. : Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther. 245, 600 (1988).
|
37 |
Hein, L. and Kobilka, B. K. : Adrenergic receptor signal transduction and regulation. Neuropharmacology 34, 357 (1995).
DOI
ScienceOn
|
38 |
Lomasney, J. W., Cotecchia, S., Lorenz, W., Leung, W. Y., Schwinn, D. A., Yang-Feng, T. L., Brownstein, M., Lefkowitz, R. J. and Caron, M. G. : Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J. Biol. Chem. 266, 6365 (1991).
|